289
Participants
Start Date
December 31, 2011
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
SAR302503
"Pharmaceutical form:capsule~Route of administration: oral"
Placebo
"Pharmaceutical form:capsule~Route of administration: oral"
Investigational Site Number 158001, Taipei
Investigational Site Number 158002, Changhua
Investigational Site Number 158003, Kaohsiung City
Investigational Site Number 040001, Vienna
Investigational Site Number 348002, Budapest
Investigational Site Number 710003, Johannesburg
Investigational Site Number 036003, Randwick
Investigational Site Number 056003, Antwerp
Investigational Site Number 710002, Parktown
Investigational Site Number 036004, Tweed Heads
Investigational Site Number 056001, Leuven
Investigational Site Number 036001, Box Hill
Investigational Site Number 348003, Miskolc
Investigational Site Number 036002, Wodonga
Investigational Site Number 036005, Herston
Investigational Site Number 348001, Debrecen
Investigational Site Number 348006, Kecskemét
Investigational Site Number 348007, Győr
Investigational Site Number 250006, Marseille
Investigational Site Number 752001, Stockholm
Investigational Site Number 380003, Varese
Investigational Site Number 380002, Bergamo
Investigational Site Number 380001, Pavia
Investigational Site Number 380006, Pavia
Investigational Site Number 724002, Madrid
Investigational Site Number 250004, Nîmes
Investigational Site Number 250003, Toulouse
Investigational Site Number 376003, Haifa
Investigational Site Number 380007, Bologna
Investigational Site Number 250005, Nantes
Investigational Site Number 840002, Canton
Investigational Site Number 380004, Florence
Investigational Site Number 276006, Aachen
Investigational Site Number 376002, Tel Litwinsky
Investigational Site Number 276007, Bonn
Investigational Site Number 840008, Rochester
Investigational Site Number 276001, Mannheim
Investigational Site Number 250002, Pierre-Bénite
Investigational Site Number 840013, Baton Rouge
Investigational Site Number 484001, Querétaro
Investigational Site Number 840004, Houston
Investigational Site Number 250007, Poitiers
Investigational Site Number 840006, Los Angeles
Investigational Site Number 840001, La Jolla
Investigational Site Number 840012, La Jolla
Investigational Site Number 250001, Villejuif
Investigational Site Number 702002, Singapore
Investigational Site Number 643009, Moscow
Investigational Site Number 643001, Moscow
Investigational Site Number 702001, Singapore
Investigational Site Number 643008, Petrozavodsk
Investigational Site Number 643005, Saint Petersburg
Investigational Site Number 643004, Saint Petersburg
Investigational Site Number 643007, Volgograd
Investigational Site Number 643010, Nizhny Novgorod
Investigational Site Number 840014, Scottsdale
Investigational Site Number 840009, Newark
Investigational Site Number 076002, Jaú
Investigational Site Number 076004, Porto Alegre
Investigational Site Number 076001, Rio de Janeiro
Investigational Site Number 124001, Montreal
Investigational Site Number 124003, Montreal
Investigational Site Number 124002, Saint John
Investigational Site Number 276008, Dresden
Investigational Site Number 372002, Dublin
Investigational Site Number 372001, Galway
Investigational Site Number 642003, Brasov
Investigational Site Number 642006, Bucharest
Investigational Site Number 642001, Timișoara
Investigational Site Number 410007, Seoul
Investigational Site Number 440001, Kaunas
Investigational Site Number 440002, Klaipėda
Investigational Site Number 616005, Brzozów
Investigational Site Number 616002, Gdansk
Investigational Site Number 616006, Lodz
Investigational Site Number 616010, Warsaw
Investigational Site Number 616003, Wroclaw
Investigational Site Number 620005, Coimbra
Investigational Site Number 620004, Lisbon
Investigational Site Number 620001, Lisbon
Investigational Site Number 620003, Porto
Investigational Site Number 642004, Bucharest
Investigational Site Number 642002, Bucharest
Investigational Site Number 410002, Bundang-Gu
Investigational Site Number 410004, Seoul
Investigational Site Number 410003, Seoul
Investigational Site Number 410001, Seoul
Investigational Site Number 410005, Seoul
Investigational Site Number 410006, Seoul
Investigational Site Number 724001, Barcelona
Investigational Site Number 752002, Uddevalla
Investigational Site Number 826006, Belfast
Investigational Site Number 826003, Birmingham
Investigational Site Number 826002, Glasgow
Investigational Site Number 826004, Leeds
Investigational Site Number 826001, London
Investigational Site Number 826005, London
Investigational Site Number 826007, Manchester
Investigational Site Number 826008, Newcastle upon Tyne
Investigational Site Number 826009, Oxford
Investigational Site Number 826010, Southampton
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY